Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. - Wikidata - awgldk - TriplyDB

Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.

Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.

http://www.wikidata.org/entity/Q37343839

about

KIBRA: A New Gateway to Learning and Memory?Long noncoding RNAs and Alzheimer's disease Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease Omega-3 fatty acids and dementia.Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.Finding related sentence pairs in MEDLINE.Biomarkers of Alzheimer's disease: from central nervous system to periphery?Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Y682G Mutation of Amyloid Precursor Protein Promotes Endo-Lysosomal Dysfunction by Disrupting APP-SorLA Interaction.Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells.Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.Dyslipidemia and the risk of Alzheimer's disease.An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples.Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.Role of Endolysosomes in Skeletal Muscle Pathology Observed in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease.SORL1 gene, plasma biomarkers, and the risk of Alzheimer's disease for the Han Chinese population in Taiwan.The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan.The role of lipoprotein receptors on the physiological function of APP.Informatics Support for Basic Research in Biomedicine.Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.Emerging bioinformatics approaches for analysis of NGS-derived coding and non-coding RNAs in neurodegenerative diseases.Functional Roles of the Interaction of APP and Lipoprotein Receptors.beta-Secretase inhibitor potency is decreased by aberrant beta-cleavage location of the "Swedish mutant" amyloid precursor protein.Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease.Brain traffic: subcellular transport of the amyloid precursor protein.Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.

P2860

Q21129069-B36D84B8-21F0-4BC6-940A-D5EFE3C9A708 Q26740231-99746792-B15D-4DF8-ACB4-AE4AFCADEC96 Q28078442-D016FC24-03EF-4ABF-A03D-0CE326232835 Q33602402-D05DBCFE-CC88-4E8C-84DB-AA43A0C6D86F Q33794509-E1D5E8A0-3D42-4FAB-9C57-8CFA7BCA3DF3 Q34353343-0452628D-2253-424E-9D5F-5D8ADBC5CBBB Q34442605-E718D606-519A-4701-BC23-F47E04A7C0C3 Q34540333-8F6828F6-F8A6-4015-8486-3CBDB4DBCE51 Q35297339-AD47CA68-2270-4311-91CD-EA2AA7D045D6 Q35306023-A8B959CD-7B80-440F-9CB6-9C8E07F38F62 Q36093193-199B5C84-677E-4769-9E01-25A1DA09FFC1 Q36337525-93EBD388-5FDA-4A11-8DE0-1C3E15333765 Q36486210-63D2243C-57B4-430F-AD4B-56BB9BB513F2 Q36587136-52A30CCE-FF72-4DFF-8C8E-7DBC5D4745C4 Q36683066-D2268E41-CD8D-4B25-BE10-C179820EF600 Q36946758-B4DF934C-8D29-4FD6-8063-D7D9ABBBE765 Q36978700-31D696A0-2FB2-42D2-B9A9-317509698C18 Q37545602-F53F0D03-F946-414C-BD01-A68E69A487EE Q37732481-213C6133-F23C-4A62-92B6-1610C5463584 Q37938682-F74B0681-E519-4715-A3DB-257838859487 Q38371711-F4B09270-1156-45BA-A624-3CF30A535A57 Q38414035-969272E8-C545-44F8-B313-3E90BE768A65 Q38598842-28F6546A-6D8B-4748-B023-3DB0514D0A42 Q39180867-7D164104-6D7C-4CBC-BDDF-71E19F5AAF29 Q39772553-0B96F684-357C-4083-ACDB-7781CC02410B Q42736295-6914E923-7FC9-4CEC-8A4A-128D3951608F Q42930091-D94C7941-5203-41DD-A560-6CB6DB3B2315 Q43115550-1F627D73-2066-432F-975F-31A1ECD34EC0 Q53325812-A224A7B9-12E8-4AE3-80D5-05B86A4B4869

P2860

Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.

http://www.wikidata.org/entity/Q37343839

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reduction of SorLA/LR11, a sor ...... r disease cerebrospinal fluid.

@en

Reduction of SorLA/LR11, a sor ...... r disease cerebrospinal fluid.

@nl

type

label

Reduction of SorLA/LR11, a sor ...... r disease cerebrospinal fluid.

@en

Reduction of SorLA/LR11, a sor ...... r disease cerebrospinal fluid.

@nl

prefLabel

Reduction of SorLA/LR11, a sor ...... r disease cerebrospinal fluid.

@en

Reduction of SorLA/LR11, a sor ...... r disease cerebrospinal fluid.

@nl

P1433

Q37343839-29F7BBF4-B2C8-4FFB-92E1-291AF45CF37E

P1476

Q37343839-E0F41371-F72B-40BE-B5D3-8F4B2280B071

P2093

Q37343839-00240A2B-C8C9-495D-A503-8DF0164E4620

Q37343839-2BB84532-0381-4FE9-9F55-366F0F4BDD8E

Q37343839-4B77602C-0464-4937-A9FC-CF58EBFE642A

Q37343839-6ACC5047-266C-48B8-A19A-03C75B843B51

Q37343839-7070DBCE-6A2B-44F3-A2E8-8C6AD7EEB316

Q37343839-76293738-DFAC-43B4-B2FA-5C8EFFBE32FA

Q37343839-8C2192BB-5460-492B-81F2-75EABB7FA945

Q37343839-A2727E69-CF63-4F66-AAAA-EA6B770CEEC3

Q37343839-BDDAB011-0EA4-4BAD-9B0A-B9AFF3445952

Q37343839-D981AAD7-94C8-4E5B-8553-DFF7A7402224

P2860

Q37343839-04F3B20D-FA27-4A21-B839-6BB64B9EF030

Q37343839-05948BFF-B635-45A2-B388-3E3265DB7770

Q37343839-0D86F49E-39C5-4BA4-915A-578DF2C97B13

Q37343839-11F50054-9BF4-43E0-8BC4-B3A3607D1709

Q37343839-14BF3DD0-6498-4EF9-9502-A5F1FD231221

Q37343839-1EDCF6B0-A393-4C04-A6EA-B9A1ACC0142F

Q37343839-2273EEDB-DABA-4037-853D-B03D458A0D29

Q37343839-2C256704-F7BB-4ABD-ACC4-A5B7C650BE17

Q37343839-2E234397-7D47-41DA-8F4A-F86FEE1D5D8E

Q37343839-458E16C6-B53C-4CDD-A5DA-D55B7B760D7B

P304

Q37343839-A330341D-AC6A-4DE8-B5AE-28BF2F5CEAD1

P31

Q37343839-13C51A1C-2199-47E8-B56B-E814395E1CEC

P356

Q37343839-B2B5CECE-4DDE-46A8-9AFF-5556D38B960D

P433

Q37343839-7CBB4B3A-2FF5-456D-A18C-39CC329EF196

P478

Q37343839-5330354F-F018-4F64-AD1C-45792203BDB9

P50

Q37343839-759A3107-7364-4B4F-85F1-48EF7563302A

P577

Q37343839-62013604-D8C4-4668-ABB7-05C6D142D485

P5875

Q37343839-76F3E0E6-678A-437C-8732-2A47D476CF37

P698

Q37343839-A4A633BC-3266-42FE-AB73-613941A8140B

P921

Q37343839-10D7F9D6-95C7-46EE-8F2A-14C0A830665C

Q37343839-B2942E66-4121-4C48-999E-B45366A22503

P932

Q37343839-79E51EEC-96DD-46F9-9C92-ED903811C7E4

P356

ARCHNEUROL.2009.22

P1433

P1476

Reduction of SorLA/LR11, a sor ...... r disease cerebrospinal fluid.

@en

P2093

Bruce Teter

http://www.w3.org/2001/XMLSchema#string

Douglas R Galasko

http://www.w3.org/2001/XMLSchema#string

Emily R Rosario

http://www.w3.org/2001/XMLSchema#string

Greg M Cole

http://www.w3.org/2001/XMLSchema#string

John M Ringman

http://www.w3.org/2001/XMLSchema#string

Justine Pomakian

http://www.w3.org/2001/XMLSchema#string

Oliver J Ubeda

http://www.w3.org/2001/XMLSchema#string

Qiu-Lan Ma

http://www.w3.org/2001/XMLSchema#string

Sally A Frautschy

http://www.w3.org/2001/XMLSchema#string

Steven D Edland

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme

Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene.

The sorLA cytoplasmic domain interacts with GGA1 and -2 and defines minimum requirements for GGA binding

P304

448-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2009.22

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Harry V Vinters

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24276161

http://www.w3.org/2001/XMLSchema#string

P698

19364929

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

2742778

http://www.w3.org/2001/XMLSchema#string